|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/7076 | (2006.01) |
| A61K 38/21 | (2006.01) | ||
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 3099307 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15702549.5 |
| Date of filing the European patent application | 2015-01-27 | |
| (97) | Date of publication of the European application | 2016-12-07 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-18 |
| (46) | Date of publication of the claims translation | 2018-02-12 |
| (86) | Number | PCT/GB2015/050177 |
| Date | 2015-01-27 |
| (87) | Number | WO 2015/114315 |
| Date | 2015-08-06 |
| (30) | Number | Date | Country code |
| 201401465 | 2014-01-29 | GB |
| (72) |
ROACH, Arthur Henry, CH
REJDAK, Konrad, PL
|
| (73) |
Chord Therapeutics SA,
15 Avenue de Sécheron, 1202 Genéve, Switzerland,
CH
|
| (74) |
Tatjana STERLINA,
UAB "Intels", Naugarduko g. 32/2, LT-03225 Vilnius,
LT
|
| (54) | Kladribino naudojimas optinio neuromielito gydymui |
| USE OF CLADRIBINE FOR TREATING NEUROMYELITIS OPTICA |
| Payment date | Validity (years) | Amount | |
| 2025-12-17 | 12 | 289.00 EUR |
| 2027-01-27 |